Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 1805350)

1.

Assessment of enduring deficit and negative symptom subtypes in schizophrenia.

Mueser KT, Douglas MS, Bellack AS, Morrison RL.

Schizophr Bull. 1991;17(4):565-82.

2.

Positive and negative symptoms in the psychoses. Re-analysis of published SAPS and SANS global ratings.

Klimidis S, Stuart GW, Minas IH, Copolov DL, Singh BS.

Schizophr Res. 1993 Mar;9(1):11-8. Review.

PMID:
8461266
3.

[Negative schizophrenic symptoms and their detection].

Kukla F, Gold R.

Fortschr Neurol Psychiatr. 1991 Feb;59(2):60-6. Review. German.

PMID:
2026379
4.
5.

[Significance of primary negative symptoms in schizophrenic and other psychiatric patients].

Gerbaldo H, Müller-Siecheneder F.

Fortschr Neurol Psychiatr. 1996 Jun;64(6):221-7. Review. German.

PMID:
8766995
6.

Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.

Schooler NR.

Acta Psychiatr Scand Suppl. 1994;380:21-6. Review.

PMID:
7914043
7.

Negative symptoms of schizophrenia: a problem that will not go away.

Stahl SM, Buckley PF.

Acta Psychiatr Scand. 2007 Jan;115(1):4-11. Review.

PMID:
17201860
8.

Negative symptoms in schizophrenia: avolition and Occam's razor.

Foussias G, Remington G.

Schizophr Bull. 2010 Mar;36(2):359-69. doi: 10.1093/schbul/sbn094. Epub 2008 Jul 21. Review.

9.

The positive-negative distinction in schizophrenia. Review of natural history validators.

McGlashan TH, Fenton WS.

Arch Gen Psychiatry. 1992 Jan;49(1):63-72. Review.

PMID:
1728252
10.

[Social diagnosis: assessment scales and evaluation of "social adjustment" of psychiatric patients].

Gerne M, Wengle HP.

Z Klin Psychol Psychopathol Psychother. 1992;40(3):213-45. Review. German.

PMID:
1519382
11.

The three-syndrome model of schizophrenia: meta-analysis of an artefact.

Stuart GW, Pantelis C, Klimidis S, Minas IH.

Schizophr Res. 1999 Oct 19;39(3):233-42. Review.

PMID:
10507515
12.

Non-verbal behavioural dysfunction in schizophrenia. Vulnerability indicator, residual marker or coping strategy?

Gaebel W.

Br J Psychiatry Suppl. 1992 Oct;(18):65-74. Review. No abstract available.

PMID:
1389044
13.

Quality of life and its predictors in people with schizophrenia.

Tomotake M.

J Med Invest. 2011 Aug;58(3-4):167-74. Review.

14.

The negative symptoms of schizophrenia: category or continuum?

Kaiser S, Heekeren K, Simon JJ.

Psychopathology. 2011;44(6):345-53. doi: 10.1159/000325912. Epub 2011 Aug 17. Review.

15.

Measuring negative symptom change in schizophrenia: considering alternatives to self-report.

Gupta M, Holshausen K, Gou L, Bowie C.

Expert Rev Neurother. 2014 Aug;14(8):911-22. doi: 10.1586/14737175.2014.935341. Epub 2014 Jun 28. Review.

PMID:
24976136
16.

Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Messinger JW, Trémeau F, Antonius D, Mendelsohn E, Prudent V, Stanford AD, Malaspina D.

Clin Psychol Rev. 2011 Feb;31(1):161-8. doi: 10.1016/j.cpr.2010.09.002. Epub 2010 Sep 18. Review.

17.

Assessing the efficacy of treatments for the deficit syndrome of schizophrenia.

Kirkpatrick B, Kopelowicz A, Buchanan RW, Carpenter WT Jr.

Neuropsychopharmacology. 2000 Mar;22(3):303-10. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk